drug · antibody
patient view →atezolizumab
Marketedupdated 2mo agoby F. Hoffmann-La Roche Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 10 approved and 59 investigational indications.
indications
investigational
NSCLCBreast Cancer
targets
Programmed cell death 1 ligand 1
all catalysts(41)
approval · 39
phase 0 trial completion · 1
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that